LLY Trademark

Trademark Overview


On Thursday, June 14, 2018, a trademark application was filed for LLY with the United States Patent and Trademark Office. The USPTO has given the LLY trademark a serial number of 88000924. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 7, 2022. This trademark is owned by Eli Lilly and Company. The LLY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use i...
lly

General Information


Serial Number88000924
Word MarkLLY
Filing DateThursday, June 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 7, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2018

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, March 7, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 7, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 21, 2021SOU EXTENSION 5 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 5 FILED
Wednesday, June 16, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, February 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 2, 2021SOU EXTENSION 4 GRANTED
Monday, December 21, 2020SOU EXTENSION 4 FILED
Monday, January 11, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 19, 2020SOU EXTENSION 3 GRANTED
Friday, June 19, 2020SOU EXTENSION 3 FILED
Friday, June 19, 2020SOU TEAS EXTENSION RECEIVED
Friday, December 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 11, 2019SOU EXTENSION 2 GRANTED
Wednesday, December 11, 2019SOU EXTENSION 2 FILED
Wednesday, December 11, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, June 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2019SOU EXTENSION 1 GRANTED
Monday, June 17, 2019SOU EXTENSION 1 FILED
Monday, June 17, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, January 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, November 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 26, 2018ASSIGNED TO LIE
Wednesday, October 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 9, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, October 9, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 9, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, October 9, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, October 8, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 8, 2018NON-FINAL ACTION E-MAILED
Monday, October 8, 2018NON-FINAL ACTION WRITTEN
Monday, October 1, 2018ASSIGNED TO EXAMINER
Wednesday, June 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 18, 2018NEW APPLICATION ENTERED